Company Filing History:
2 out of 1,744 
1 out of 319 
1 out of 4 Years Active: 2018-2021
Title: Johanna Chiche: Innovator in Lymphoma Research
Introduction
Johanna Chiche is a prominent inventor based in Nice, France. She has made significant contributions to the field of lymphoma research, particularly in developing methods for predicting treatment responses. With a total of 2 patents, her work has the potential to impact patient care and treatment strategies.
Latest Patents
Johanna Chiche's latest patents include innovative methods for determining the metabolic status of lymphomas. One patent provides an in vitro method for assessing the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in lymphoma cells. A low level of GAPDH expression is indicative of oxidative phosphorylation (OXPHOS) status. Another patent focuses on predicting a patient's responsiveness to treatment with metabolic inhibitors based on GAPDH expression levels. Additionally, she has developed a method for predicting responsiveness to anti-CD20 antibody treatment by measuring GAPDH levels in B cells from patients.
Career Highlights
Throughout her career, Johanna Chiche has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. Her research has been instrumental in advancing the understanding of lymphoma and improving treatment outcomes for patients.
Collaborations
Johanna has collaborated with notable colleagues, including Catherine Thieblemont and Jean-Ehrland Ricci. These partnerships have further enriched her research and contributed to the development of her innovative methods.
Conclusion
Johanna Chiche's work in lymphoma research exemplifies the impact of innovation in medicine. Her patents and collaborations highlight her commitment to improving patient care through scientific advancements.